Biotech · Private company
Kaneka Medical America LLC
Track this companyFree. Adds Kaneka Medical America LLC to your Dealase workspace and tells you when its record changes.
Clinical trials64 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- i-ED COILAneurysm CerebralClinicalTrials.gov · fetched Nov 12, 2026
- LIPOSORBER® LA-15Focal Segmental GlomerulosclerosisClinicalTrials.gov · fetched Nov 12, 2026
- LIPOSORBER® LA-15 SystemFocal Segmental GlomerulosclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Lixelle® treatmentDialysis AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
- Neuro endovascular embolic coilChronic Subdural HematomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomyNOT_YET_RECRUITING · started Nov 30, 2025ClinicalTrials.gov NCT07214623 · fetched Nov 12, 2026
- Kaneka Endovascular Embolization and ProtectionNA · ACTIVE_NOT_RECRUITING · started Dec 13, 2022ClinicalTrials.gov NCT05563051 · fetched Nov 12, 2026
- Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 SystemNA · RECRUITING · started Jan 1, 2020ClinicalTrials.gov NCT04065438 · fetched Nov 12, 2026
- LDL-Apheresis for FSGS CardioRenal OutcomesCOMPLETED · started Jan 1, 2019ClinicalTrials.gov NCT04088799 · fetched Nov 12, 2026
- Post Approval Study of Lixelle for the Treament of Dialysis-Related AmyloidosisNA · SUSPENDED · started Oct 1, 2015ClinicalTrials.gov NCT02952144 · fetched Nov 12, 2026
- Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in ChildrenNA · RECRUITING · started May 3, 2015ClinicalTrials.gov NCT02235857 · fetched Nov 12, 2026